Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells

Immunopharmacology

Volumn 35, Issue 2, 1996, Pages 141-148

  Okuda, Yoshinobu ^a   Sakoda, Saburo ^a   Fujimura, Harutoshi ^a   Yanagihara, Takehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

cytokine; experimental allergic encephalomyelitis; multiple sclerosis; pentoxifylline; semiquantitative reverse transcriptase polymerase chain reaction

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-1; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED STRAINS; PENTOXIFYLLINE; POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030298571     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(96)00139-7     Document Type: Article

References (30)

1. Baker, D., O'Neill, J.K. and Turk, J.L., 1991. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol., 34: 505-510.
2. Bemelmans, M.H.A., Abramowicz, D., Gouma, D.J., Golman, M., Buurman, W.A., 1994. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. J. Immunol., 153: 499-506.
3. Bianco, J.A., Appelbaum, F.R., Nemunaitis, J., Almgren, J., Andrews, F., Kettner, P., Shields, A. and Singer, J.W., 1991. Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood, 78: 1205-1211.
4. Chantry, D.M., Turner, M., Abney, E. and Feldmann, M., 1989. Modulation of cytokine production by transforming growth factor-β1. J. Immunol., 142: 4295-4300.
5. Ferber, I.A., Brocke, S., Edwards, C.T., Ridgway, W., Dinisco, C., Steinman, L., Daiton, D. and Fathman, C.G., 1996. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol., 156: 5-7.
6. Gan, X., Robin, J.P., Huerta, J.M.M., Braquet, P. and Bonavida, B., 1994. Inhibition of tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative. J. Clin. Immunol., 14: 280-288.
7. Han, J., Thompson, P. and Beutler, B., 1990. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin: tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med., 72: 391-394.
8. Issazadeh, S., Mustafa, M., Liungdahl, Å., Höjeberg, B., Dagerlind, Å., Elde, R. and Olsson, T., 1995a. Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmne encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res., 40: 579-590.
9. Issazadeh, S., Liungdahl, Å., Hojeberg, B., Mustafa, M. and Olsson, T., 1995b. Cytokine production in the central nervous system of Lewis rat with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β. J. Neuroimmunol., 61: 205-212.
10. Jewett, A. and Bonavida, B., 1994. Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion. J. Clin. Immunol., 14: 31-38.
11. Kartin, N., Mitchell, D.J., Brocke, S., Ling, N. and Steinman, L., 1994. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon γ and tumor necrosis factor a production. J. Exp. Med., 180: 2227-2237.
12. Kim, K.J., Abrams, J., Alphonso, M., Pearce, M., Thorbecke, G.J. and Palladino, M.A., 1990. Role of endogenously produced interleukin-6 as a second signal in murine thymocyte proliferation induced by multiple cytokines: regulatory effects of transforming growth factor-β1. Cell Immunol., 131: 261-271.
13. Landman, D., Sarai, A. and Sathe, S.S., 1994. Use of pentoxifylline therapy for patients with AIDS-related wasting: pilot study. Clin Infect Diseases, 18: 97-99.
14. Levi, M., Cate, H., Bauer, K.A., Poll, T., Edgington, T.S., Büller, H.R., Deventer, S.J.H., Hack, C.E., Cate, J.W. and Rosenberg, R.D., 1994. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J. Clin. Invest., 93: 114-120.
15. Nataf, S., Louboutin, J.P., Chabannes, D., Feve, J.R. and Muller, J.Y., 1993. Pentoxifylline inhibits experimental allergic encephalomyelitis. Acta Neurol. Scand., 88: 97-99.
16. Neuner, P., Klosner, G., Schauer, E., Pourmojib, M., Macheiner, W., Grünwald, C., Knobler, R., Schwarz, A., Luger, T.A. and Schwarz, T., 1994. Pentoxifylline in vivo down-regulates the release of IL-1β, IL-6, IL-8 and tumor necrosis factor-α by human peripheral blood mononuclear cells. Immunology, 83: 262-267.
17. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T. and Sakoda, S., 1995. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol., 62: 103-112.
18. Olsson, T., 1992. Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interteron-gamma. J. Neuroimmunol., 40: 211-218.
19. Powell, M.B., Mitchell, D., Lederman, J., Buckmeier, J., Zamvil, S.S., Graham, M., Ruddle, N.H. and Steinman, L., 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein specific T cell clones correlates with encephalitogenicity. Int. Immunol., 2: 539-544.
20. Racke, M.K., Jalbut, S.D., Cannella, B., Albert, P.S., Raine, C.S. and Mcfarlin, D.E., 1991. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol., 146: 3012-3017.
21. Renno, T., Krakowski, M., Piccirillo, C., Lin, J. and Owens, T., 1995. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. J. Immunol., 154: 944-953.
22. Rickmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., Helwig, A. and Poser, S., 1995. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol., 37: 82-88.
23. Rieneck, K., Diamant, M., Haahr, P.M., Schönharting, M. and Bendtzen, K., 1993. In vitro immunomodularory effects of pentoxifylline. Immunol. Lett., 37: 131-138.
24. Rott, O., Cash, E. and Fleische, B., 1993. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol., 23: 1745-751.
25. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Grunnet, M.L., Padula, S.J. and Clark, R.B., 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med., 172: 1193-1200.
26. Santambrogio, L., Hochwald, G.M., Saxena, B., Leu, C.H., Martz, J.E., Carlino, J.A., Ruddle, N.H., Palladino, M.A., Gold, L.I. and Thorbecke, G.J., 1993. Studies on the mechanism by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J. Immunol., 151: 1116-1127.
27. Schandene, L., Vandenbussche, P., Crusiaux, A., Alègre, M.L., Abramowicz, D., Dupont, E., Content, J. and Goldman, M., 1992. Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) by monocytes and T cells. Immunology, 76: 30-34.
28. Selmaj, K., Raine, C.S. and Cross, A.H., 1991. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol., 30: 694-700.
29. Tilg, H., Eibl, B., Pichl, M., Gächter, A., Herold, M., Brankova, J., Huber, C. and Niederwieser, D., 1993. Immune response modulation by pentoxifylline in vitro. Transplantation, 56: 196-201.
30. Willenborg, D.O., Fordham, S.A., Cowden, W.B. and Ramshaw, I.A., 1995. Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41: 31-41.